NCBI PubMed Central
open access
A translational neuroscience & computational evaluation of a D1R partial agonist for schizophrenia (TRANSCENDS): Rationale and study design of a brain-based clinical trial.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Emerging non-D(2) receptor-based therapies for schizophrenia: a focus on muscarinic and glutamatergic pathways.#402467
- D-serine Monotherapy for Schizophrenia#884301
- Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen#876230
- A Long-term Trial of OPC-34712 in Patients With Schizophrenia#872487
- Clinical phenotypes and early treatment escalation in pediatric acute drug-induced dystonia: A tertiary emergency department cohort study.#366356
Record · ID 154241
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive